Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page
- Check7 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No substantive content changes are visible.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedAdded a new site revision note: v3.4.2. The notices about government funding lapse and the older revision v3.4.1 were removed.SummaryDifference0.4%

- Check50 days agoChange DetectedThe page now includes a government funding lapse notice and a new revision label v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check57 days agoChange DetectedShow glossary added and minor wording/capitalization changes to update metadata (e.g., 'Last Update Submitted that Met QC Criteria' vs 'Last Update Submitted that met QC Criteria'; 'No FEAR Act Data' vs 'No FEAR Act data'), plus 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedRevision tag updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.